Skip to main content
All lobbying filings

Everylife Foundation for Rare Diseases

Everylife Foundation for Rare Diseases filed a Q2 report for Everylife Foundation for Rare Diseases on July 17, 2026.

Lobbying for Everylife Foundation for Rare Diseases

As filed: EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES.

All filings by Everylife Foundation for Rare Diseases · Everything Everylife Foundation for Rare Diseases has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Expenses
$40,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

S. 822, H.R. 1532 - Scientific EXPERT Act of 2025; H.R. 4709 - Newborn Screening Saves Lives Reauthorization Act of 2025; FY 2027 Appropriations; FDA user fee reauthorization; H.R. 7118 - Genomic Answers for Children's Health Act; H.R. 5509, S. 2903 - Safe Step Act; H.R. 1414 - Cameron's Law

 Bills named in this filing 7

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem